Queensland study reveals why parents say yes or no to RSV shot for babies

NCT ID NCT07615192

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how many eligible infants in Queensland receive the RSV immunisation (nirsevimab) during their first RSV season. Researchers will survey 1,200 parents to understand why they chose for or against the shot, and look at factors like location and health risks. No treatment is given—the study simply collects real-world data to improve future vaccination programs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help public health officials understand RSV vaccine uptake and improve immunisation strategies for infants.

What could go wrong

This is an observational study, not a treatment trial. It only measures current vaccination rates and parent attitudes, so it won't directly change health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RSV IMMUNIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Paratus Clinical Research

    RECRUITING

    Brisbane, Queensland, 4006, Australia